Spinocerebellar Ataxias
Neurology
2
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
1
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
+ 1 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
BiohavenNEW HAVEN, CT
3 programs1
1
troriluzolePhase 3Small Molecule1 trial
TroriluzolePhase 2/3Small Molecule1 trial
BHV-4157N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Biohaventroriluzole
BiohavenTroriluzole
BiohavenBHV-4157
Clinical Trials (3)
Troriluzole in Adult Participants With Spinocerebellar Ataxia
Start: Mar 2019Est. completion: Jun 2026
Phase 3Active Not Recruiting
Trial in Adult Participants With Spinocerebellar Ataxia (SCA)
Start: Dec 2016Est. completion: Sep 2024
Phase 2/3Completed
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
Start: Mar 2019Est. completion: Jun 2026
N/AActive Not Recruiting
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
8h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
8h ago
Director of Finance
CoMind
London, UK
8h ago
Electronics Engineering Manager
CoMind
London, UK
8h ago
Director of Information Technology
Zavation Medical Products
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
Small Molecule is the dominant modality (100% of programs)
1 companies competing in this space